Viracta Therapeutics

Presence

Viracta Therapeutics is a company listed under the stock ticker VIRX (US).

Executives

View the org chart displaying its 20 main executives

Most searched biographies at Viracta Therapeutics
Popular executive movements at Viracta Therapeutics
  • Michael Faerm has joined the company as Chief Financial Officer  (posted on May 15 2024).
  • Dan Chevallard, Chief Operating Officer and Chief Financial Officer, has left the company  (posted on March 22 2024).

Create your alert
to follow the executive moves at Viracta Therapeutics.

Biotechnology

Viracta Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry >

News

Press releases by Viracta Therapeutics
Social media about Viracta Therapeutics

Get in Touch

Contact by email its executives including Mark Rothera Premium

Call Viracta Therapeutics at +1 858...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Executive Data Sets
Executives
Companies
The Official Board